title: [The Experimental Model of Autoimmune Process: the Role of Epigenetic Variation in the Population of Mice Hybrids].
abstract: BACKGROUND
  At the development of graft versus host disease in genetically homogeneous population of (C57BI/6 x DBA/2) Fl mice two clinical phenotypes of SLE-like disease were revealed: lupus+ (immune complex glomerulonephritis and hemnolytic anemia) and lupus - (hemolytic anemia). The GvHD phenotypic heterogeneity is determined by the Th2-polarization: Th2 lymphocyte predominant activity, leads to the lupus+development, or prevalence activity of Th1 cells, leads to the lupus- development.
  
  
  OBJECTIVE
  Our aim was to evaluate the possibility of using an experimental model of autoimmnune disease for studying and testing of epigenetic modifications, shifting Th1/Th2 balance in vivo.
  
  
  METHODS
  Chronic GVHD was induced in B6D2F1 mice by the transplantation of 130x10(6) parental DBA/2 splenocytes. Anti-ds-DNA, total IgG and IgGI, IgG2a Abs were measured by ELISA.
  
  
  RESULTS
  Six- to 8-week-old female DBA/2 and B6D2F1 mice were obtained from Biological Research Laboratory (Novosibirsk). It was established that regular moderate physical activity (unladed swimming) shifted Th1/Th2 balance towards Th1. This leads to a decrease in a population of recipients the lupus+ mice from 57 to 26% (p <0,001) with significantly reduced hypergammaglobulinemia (IgG from 2,8 to 2,0 mg/ml; p <0,047) and DNA antibodies titer from 0,18 to 0,12 OD (p =0,05). Administration of epigenetic modificator bisphenol A at low doses, which mimicking estrogen effects, enhances the proportion of lupus+ mice in experimental groups from 33 to 64% (p <0,001) and impairs their clinical status by the increasing the urine protein level from 2.8 to 4,2 mg/ml (p <0,001) in animals.
  
  
  CONCLUSIONS
  Th1/Th2 - balance presumably is determined by the immune system epigenetic modification in experimental mice, formed on the previous stages of ontogeny and defines the direction of immune processes development in individual animal.
authors.forename: O P
authors.initials: OP
authors.lastname: Kolesnikova
authors.forename: O T
authors.initials: OT
authors.lastname: Kudaeva
authors.forename: N N
authors.initials: NN
authors.lastname: Volsky
authors.forename: E V
authors.initials: EV
authors.lastname: Goiman
authors.forename: E D
authors.initials: ED
authors.lastname: Gavrilova
authors.forename: O M
authors.initials: OM
authors.lastname: Perminova
authors.forename: E N
authors.initials: EN
authors.lastname: Demchenko
authors.forename: V A
authors.initials: VA
authors.lastname: Kozlov
mesh_terms: D000818:Animals; D001327:Autoimmune Diseases / Q000235:genetics* / Q000276:immunology; D015551:Autoimmunity / Q000235:genetics*; D004195:Disease Models, Animal; D004797:Enzyme-Linked Immunosorbent Assay; D057890:Epigenomics / Q000379:methods*; D005260:Female; D006086:Graft vs Host Disease / Q000235:genetics* / Q000276:immunology; D007136:Immunoglobulins / Q000276:immunology; D007684:Kidney Tubules / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D013154:Spleen / Q000276:immunology / Q000637:transplantation; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D007136:Immunoglobulins